LEADER 01545oam  2200385Ia 450 
001 9910698827203321
005 20090915154040.0
035   $a(CKB)5470000002397596
035   $a(OCoLC)355390908
035   $a(EXLCZ)995470000002397596
100   $a20090528d2001      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for clinical trial sponsors$b[electronic resource] $eon the establishment and operation of clinical trial data monitoring committees
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research :$cCenter for Drug Evaluation and Research :$cCenter for Devices and Radiological Health,$d[2001]
215   $aii, 23 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on May 28, 2009).
300   $a"Draft guidance".
300   $a"November 2001".
517   $aGuidance for clinical trial sponsors 
606   $aClinical trials$xGovernment policy$zUnited States
615  0$aClinical trials$xGovernment policy
712 02$aCenter for Biologics Evaluation and Research (U.S.)
712 02$aCenter for Drug Evaluation and Research (U.S.)
712 02$aCenter for Devices and Radiological Health (U.S.)
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910698827203321
996   $aGuidance for clinical trial sponsors$93509397
997   $aUNINA